Cold chain and virus-free oral polio booster vaccine made in lettuce chloroplasts confers protection against all three poliovirus serotypes

Plant Biotechnology Journal

Volumn 17, Issue 7, 2019, Pages 1357-1368

  Daniell, Henry ^a   Rai, Vineeta ^a   Xiao, Yuhong ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

bioencapsulation; human infectious diseases; lettuce chloroplast transformation; mucosal immunity; oral delivery; Polio viral protein 1

Indexed keywords

ORAL POLIOMYELITIS VACCINE; VIRUS ANTIBODY;

ANIMAL; BIOSYNTHESIS; BLOOD; CHLOROPLAST; FEMALE; LETTUCE; METABOLISM; MOUSE; POLIOMYELITIS; POLIOMYELITIS VIRUS; REFRIGERATION; SECONDARY IMMUNIZATION; SERODIAGNOSIS; SEROTYPE; TRANSGENIC PLANT;

ANIMALS; ANTIBODIES, VIRAL; CHLOROPLASTS; FEMALE; IMMUNIZATION, SECONDARY; LETTUCE; MICE; NEUTRALIZATION TESTS; PLANTS, GENETICALLY MODIFIED; POLIOMYELITIS; POLIOVIRUS; POLIOVIRUS VACCINE, ORAL; REFRIGERATION; SEROGROUP;

EID: 85067556772     PISSN: 14677644     EISSN: 14677652     Source Type: Journal    
DOI: 10.1111/pbi.13060     Document Type: Article

References (51)

1. Allen, G.C., Flores-Vergara, M.A., Krasynanski, S., Kumar, S. and Thompson, W.F. (2006) A modified protocol for rapid DNA isolation from plant tissues using cetyltrimethylammonium bromide. Nat. Protoc. 1, 2320–2325.
2. Arlen, P.A., Falconer, R., Cherukumilli, S., Cole, A., Cole, A.M., Oishi, K.K. and Daniell, H. (2007) Field production and functional evaluation of chloroplast-derived interferon-alpha2b. Plant Biotechnol. J. 5, 511–525.
3. Bachmann, M.F. and Jennings, G.T. (2010) Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns. Nat. Rev. Immunol. 10, 787–796.
4. Baldauf, K.J., Royal, J.M., Hamorsky, K.T. and Matoba, N. (2015) Cholera toxin B: one subunit with many pharmaceutical applications. Toxins, 7, 974–996.
5. Boyhan, D. and Daniell, H. (2011) Low-cost production of proinsulin in tobacco and lettuce chloroplasts for injectable or oral delivery of functional insulin and C-peptide. Plant Biotechnol. J. 9, 585–598.
6. Byberg, S. and Fisker, A.B. (2016) Is introduction of IPV “Good news for billions of children?” Lancet Infect. Dis. 16, 409.
7. Chan, H.T., Xiao, Y., Weldon, W.C., Oberste, S.M., Chumakov, K. and Daniell, H. (2016) Cold chain and virus-free chloroplast-made booster vaccine to confer immunity against different poliovirus serotypes. Plant Biotechnol. J. 14, 2190–2200.
8. Chen, Q. and Lai, H. (2013) Plant-derived virus-like particles as vaccines. Hum. Vaccin. Immunother. 9, 26–49.
9. Chen, L., Zhang, J. and Sun, H. (2015) Immunological adjuvant effect of the peptide fraction from the larvae of Musca domestica. BMC Complement Altern. Med. 15, 427.
10. Daniell, H., Chan, H.T. and Pasoreck, E.K. (2016) Vaccination via chloroplast genetics: affordable protein drugs for the prevention and treatment of inherited or infectious human diseases. Annu. Rev. Genet. 50, 595–618.
11. Davoodi-Semiromi, A., Schreiber, M., Nalapalli, S., Verma, D., Singh, N.D., Banks, R.K., Chakrabarti, D. et al. (2010) Chloroplast-derived vaccine antigens confer dual immunity against cholera and malaria by oral or injectable delivery. Plant Biotechnol. J. 8, 223–242.
12. Diop, O.M., Burns, C.C., Sutter, R.W., Wassilak, S.G., Kew, O.M. and Centers for Disease C Prevention (2015) Update on vaccine-derived polioviruses – Worldwide, January 2014-March 2015. MMWR Morb. Mortal. Wkly Rep. 64, 640–646.
13. Fernandez-San Millan, A., Mingo-Castel, A., Miller, M. and Daniell, H. (2003) A chloroplast transgenic approach to hyper-express and purify Human Serum Albumin, a protein highly susceptible to proteolytic degradation. Plant Biotechnol. J. 1, 71–79.
14. Frey, A., Di Canzio, J. and Zurakowski, D. (1998) A statistically defined endpoint titer determination method for immunoassays. J. Immunol. Methods, 221, 35–41.
15. Grgacic, E.V. and Anderson, D.A. (2006) Virus-like particles: passport to immune recognition. Methods, 40, 60–65.
16. Gupta, K., Kotian, A., Subramanian, H., Daniell, H. and Ali, H. (2015) Activation of human mast cells by retrocyclin and protegrin highlight their immunomodulatory and antimicrobial properties. Oncotarget, 6, 28573–28587.
17. Herzog, R.W., Nichols, T.C., Su, J., Zhang, B., Sherman, A., Merricks, E.P., Raymer, R. et al. (2017) Oral tolerance induction in hemophilia b dogs fed with transplastomic lettuce. Mol. Ther. 25, 512–522.
18. Hird, T.R. and Grassly, N.C. (2012) Systematic review of mucosal immunity induced by oral and inactivated poliovirus vaccines against virus shedding following oral poliovirus challenge. PLoS Pathog. 8, 19.
19. Holmes, M., Abimbola, T., Lusiana, M., Pallas, S., Hampton, L.M., Widyastuti, R., Muas, I. et al. (2017) Resource needs for the trivalent oral polio to bivalent oral polio vaccine switch in Indonesia. J. Infect. Dis. 216, S209–S216.
20. Jorba, J., Diop, O.M., Iber, J., Henderson, E., Sutter, R.W., Wassilak, S.G.F. and Burns, C.C. (2017) Update on vaccine-derived polioviruses – Worldwide, January 2016-June 2017. MMWR Morb. Mortal. Wkly Rep. 66, 1185–1191.
21. Kanagaraj, A.P., Verma, D. and Daniell, H. (2011) Expression of dengue-3 premembrane and envelope polyprotein in lettuce chloroplasts. Plant Mol. Biol. 76, 323–333.
22. Khetsuriani, N., Perehinets, I., Nitzan, D., Popovic, D., Moran, T., Allahverdiyeva, V., Huseynov, S. et al. (2017) Responding to a cVDPV1 outbreak in Ukraine: implications, challenges and opportunities. Vaccine, 35, 4769–4776.
23. Koya, V., Moayeri, M., Leppla, M.S.H. and Daniell, H. (2005) Plant-based vaccine: mice immunized with chloroplast-derived anthrax protective antigen survive anthrax lethal toxin challenge. Infect. Immun. 73, 8266–8274.
24. Kumar, S. and Daniell, H. (2004) Engineering the chloroplast genome for hyperexpression of human therapeutic proteins and vaccine antigens. Methods Mol. Biol. 267, 365–383.
25. Kushnir, N., Streatfield, S.J. and Yusibov, V. (2012) Virus-like particles as a highly efficient vaccine platform: diversity of targets and production systems and advances in clinical development. Vaccine, 31, 58–83.
26. Kwon, K.C. and Daniell, H. (2015) Low-cost oral delivery of protein drugs bioencapsulated in plant cells. Plant Biotechnol. J. 13, 1017–1022.
27. Kwon, K.C. and Daniell, H. (2016) Oral delivery of protein drugs bioencapsulated in plant cells. Mol. Ther. 24, 1342–1350.
28. Kwon, K.C., Chan, H.T., Leon, I.R., Williams-Carrier, R., Barkan, A. and Daniell, H. (2016) Codon-optimization to enhance expression yields insights into chloroplast translation. Plant Physiol. 172, 62–77.
29. Kwon, K.C., Sherman, A., Chang, W.J., Kamesh, A., Biswas, M., Herzog, R.W. and Daniell, H. (2018) Expression and assembly of largest foreign protein in chloroplasts: oral delivery of human FVIII made in lettuce chloroplasts robustly suppresses inhibitor formation in haemophilia A mice. Plant Biotechnol. J. 16, 1148–1160.
30. Lakshmi, P.S., Verma, D., Yang, X., Lloyd, B. and Daniell, H. (2013) Low cost tuberculosis vaccine antigens in capsules: expression in chloroplasts, bio-encapsulation, stability and functional evaluation in vitro. PLoS One, 8, 23.
31. Lenzi, P., Scotti, N., Alagna, F., Tornesello, M.L., Pompa, A., Vitale, A., De Stradis, A. et al. (2008) Translational fusion of chloroplast-expressed human papillomavirus type 16 L1 capsid protein enhances antigen accumulation in transplastomic tobacco. Transgenic Res. 17, 1091–1102.
32. Lund, N., Andersen, A., Hansen, A.S.K., Jepsen, F.S., Barbosa, A., Biering-Sørensen, S., Rodrigues, A. et al. (2015) The effect of oral polio vaccine at birth on infant mortality: a randomized trial. Clin. Infect. Dis. 61, 1504–1511.
33. Marsian, J. and Lomonossoff, G.P. (2016) Molecular pharming – VLPs made in plants. Curr. Opin. Biotechnol. 37, 201–206.
34. Marsian, J., Fox, H., Bahar, M.W., Kotecha, A., Fry, E.E., Stuart, D.I., Macadam, A.J. et al. (2017) Plant-made polio type 3 stabilized VLPs-a candidate synthetic polio vaccine. Nat. Commun. 8, 245.
35. McCarthy, K.A., Chabot-Couture, G., Famulare, M., Lyons, H.M. and Mercer, L.D. (2017) The risk of type 2 oral polio vaccine use in post-cessation outbreak response. BMC Med. 15, 175.
36. Minor, P. (2009) Vaccine-derived poliovirus (VDPV): impact on poliomyelitis eradication. Vaccine, 27, 2649–2652.
37. Previsani, N., Singh, H., St Pierre, J., Boualam, L., Fournier-Caruana, J., Sutter, R.W., Zaffran, M. et al. (2017) Progress toward containment of poliovirus type 2 – Worldwide, 2017. MMWR Morb. Mortal. Wkly Rep. 66, 649–652.
38. Ramirez Gonzalez, A., Farrell, M., Menning, L., Garon, J., Everts, H., Hampton, L.M., Dolan, S.B. et al. (2017) Implementing the synchronized global switch from trivalent to bivalent oral polio vaccines-lessons learned from the global perspective. J. Infect. Dis. 216, S183–S192.
39. Rennels, M.B. (2009) Need for polio boosters after age two years. Vaccine, 27, 179–180.
40. Roldao, A., Mellado, M.C., Castilho, L.R., Carrondo, M.J. and Alves, P.M. (2010) Virus-like particles in vaccine development. Expert Rev. Vaccines, 9, 1149–1176.
41. Ruhlman, T., Ahangari, R., Devine, A., Samsam, M. and Daniell, H. (2007) Expression of cholera toxin B-proinsulin fusion protein in lettuce and tobacco chloroplasts-oral administration protects against development of insulitis in non-obese diabetic mice. Plant Biotechnol. J. 5, 495–510.
42. Ruhlman, T., Verma, D., Samson, N. and Daniell, H. (2010) The role of heterologous chloroplast sequence elements in transgene integration and expression. Plant Physiol. 152, 2088–2104.
43. Sherman, A., Su, J., Lin, S., Wang, X., Herzog, R.W. and Daniell, H. (2014) Suppression of inhibitor formation against FVIII in a murine model of hemophilia A by oral delivery of antigens bioencapsulated in plant cells. Blood, 124, 1659–1668.
44. Stratmann, T. (2015) Cholera toxin subunit B as adjuvant-an accelerator in protective immunity and a break in autoimmunity. Vaccines, 3, 579–596.
45. Su, J., Zhu, L., Sherman, A., Wang, X., Lin, S., Kamesh, A., Norikane, J.H. et al. (2015) Low cost industrial production of coagulation factor IX bioencapsulated in lettuce cells for oral tolerance induction in hemophilia B. Biomaterials, 70, 84–93.
46. Verma, D., Moghimi, B., LoDuca, P.A., Singh, H.D., Hoffman, B.E., Herzog, R.W. and Daniell, H. (2010) Oral delivery of bioencapsulated coagulation factor IX prevents inhibitor formation and fatal anaphylaxis in hemophilia B mice. Proc. Natl. Acad. Sci. USA, 107, 7101–7106.
47. Waheed, M.T., Thones, N., Muller, M., Hassan, S.W., Razavi, N.M., Lossl, E., Kaul, H.P. et al. (2011) Transplastomic expression of a modified human papillomavirus L1 protein leading to the assembly of capsomeres in tobacco: a step towards cost-effective second-generation vaccines. Transgenic Res. 20, 271–282.
48. Worstell, N.C., Krishnan, P., Weatherston, J.D. and Wu, H.J. (2016) Binding cooperativity matters: a GM1-like ganglioside-cholera toxin B subunit binding study using a nanocube-based lipid bilayer array. PLoS One, 11, e0153265.
49. Xiao, Y. and Daniell, H. (2017) Long-term evaluation of mucosal and systemic immunity and protection conferred by different polio booster vaccines. Vaccine, 35, 5418–5425.
50. Xiao, Y., Kwon, K.C., Hoffman, B.E., Kamesh, A., Jones, N.T., Herzog, R.W. and Daniell, H. (2016) Low cost delivery of proteins bioencapsulated in plant cells to human non-immune or immune modulatory cells. Biomaterials, 80, 68–79.
51. Yaari, R., Kaliner, E., Grotto, I., Katriel, G., Moran-Gilad, J., Sofer, D., Mendelson, E. et al. (2016) Modeling the spread of polio in an IPV-vaccinated population: lessons learnedfrom the 2013 silent outbreak in southern Israel. BMC Med. 14, 95.